Načítá se...

Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response

Treatment of chronic hepatitis C virus (HCV) infection is evolving rapidly with the development of novel direct acting antivirals (DAAs), however viral clearance remains intimately linked to the hepatic innate immune system. Patients demonstrating a high baseline activation of interferon stimulated...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Read, Scott A., Tay, Enoch S., Shahidi, Mahsa, O’Connor, Kate S., Booth, David R., George, Jacob, Douglas, Mark W.
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4551482/
https://ncbi.nlm.nih.gov/pubmed/26313459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0136227
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!